Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Retained Earnings (2016 - 2025)

Marimed has reported Retained Earnings over the past 15 years, most recently at -$127.9 million for Q4 2025.

  • Quarterly Retained Earnings fell 12.77% to -$127.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$127.9 million through Dec 2025, down 12.77% year-over-year, with the annual reading at -$127.9 million for FY2025, 12.77% down from the prior year.
  • Retained Earnings was -$127.9 million for Q4 2025 at Marimed, down from -$123.3 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$83.9 million in Q4 2022 and troughed at -$127.9 million in Q4 2025.
  • The 5-year median for Retained Earnings is -$98.7 million (2021), against an average of -$100.4 million.
  • Year-over-year, Retained Earnings grew 16.42% in 2021 and then dropped 20.32% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$97.4 million in 2021, then rose by 13.83% to -$83.9 million in 2022, then decreased by 19.1% to -$100.0 million in 2023, then fell by 13.5% to -$113.4 million in 2024, then dropped by 12.77% to -$127.9 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Retained Earnings are -$127.9 million (Q4 2025), -$123.3 million (Q3 2025), and -$118.8 million (Q2 2025).